aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 10, 2025 SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that Sanjay S. Shukla, M.D., […]

Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference GlobeNewswire November 10, 2025 EMERYVILLE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) — Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, Chief Executive Officer of Kyverna, will present at

Aligos Therapeutics Presents Positive Data at The Liver Meeting(R) 2025 Oral presentation of 96-week treatment and post-treatment data suggest best-in-class potential of pevifoscorvir sodium GlobeNewswire November 10, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class

1st Chance Finance Announces Official Launch of New Unique Platform to Help Parents Open, Fund, and Manage Custodial IRA Accounts for Minors GlobeNewswire November 10, 2025 New York, NY, Nov. 10, 2025 (GLOBE NEWSWIRE) — 1st Chance Finance is thrilled to announce the launch of its unique platform, designed to help parents and guardians open,

U.S. Dental Services Market Size Expected to Reach USD 254.70 Billion by 2034 The U.S. dental services market size is calculated at USD 172.6 billion in 2025 and is expected to reach around USD 254.7 billion by 2034, growing at a CAGR of 4.4% for the forecasted period. GlobeNewswire November 10, 2025 Ottawa, Nov. 10,

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results GlobeNewswire November 10, 2025 -Positive Phase 1 data for CTX310(R) presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions and simultaneously published in The New England Journal of Medicine– -CASGEVY(R) momentum accelerating; nearly 300 patients have been referred to

Belite Bio Reports Third Quarter 2025 Financial Results and Provides a Corporate Update GlobeNewswire November 10, 2025 Completed enrollment with 530 subjects in the pivotal phase 3 PHOENIX trial in geographic atrophy (GA) Completed $15 million registered direct offering and $125 million private placement with potential for up to an additional $165 million upon full

Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) GlobeNewswire November 10, 2025 New York, Nov. 10, 2025 (GLOBE NEWSWIRE) — Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an update note on MAIA Biotechnology, Inc. (NYSE: MAIA) following quarterly results. The

Aventis Energy Bolsters Targets Along Uranium Trends at the Corvo Uranium Project with KorrAI Technologies GlobeNewswire November 10, 2025 VANCOUVER, British Columbia, Nov. 10, 2025 (GLOBE NEWSWIRE) — Aventis Energy Inc. (“Aventis” or the “Company“) (CSE: AVE | FRA: C0O0 | OTC: VBAMF) is pleased to announce that, in partnership with KorrAI Technologies Inc. (“KorrAI“),

ProCap BTC and Columbus Circle Capital Corp I Announce Effectiveness of Form S-4 and Date for Extraordinary General Meeting to Approve Business Combination GlobeNewswire November 10, 2025 â— Extraordinary General Meeting of Shareholders to be held on December 3, 2025 â— ProCap BTC explores potential strategic opportunities with key partners and industry leaders New York,